complements 1MQs metabolic shift for better energy and recovery
In the Wegovy-pill clinical trial, 18% of people who received the medication discontinued the treatment, which was less than the 26% rate in the placebo group
Weight Loss Results: What Clinical Trials Show Numbers can be reassuring, but they can also be misleading if you take them out of context
17,853 reports mention obesity as indication, 283,238 mention T2D as indication, and 1,615 mention both (Additional file 1: Table S1)
For instance, they clearly explain whats included in monthly fees, what isnt, and how long you may need to stay on the medication